Atıf İçin Kopyala
Yurtogullari S., Rahmanlar H., Alkan A., Bayar B., Gursoz H., UZUN ADATEPE N.
TURKISH JOURNAL OF NEUROLOGY, cilt.26, sa.3, ss.235-241, 2020 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
26
Sayı:
3
-
Basım Tarihi:
2020
-
Doi Numarası:
10.4274/tnd.2020.37791
-
Dergi Adı:
TURKISH JOURNAL OF NEUROLOGY
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.235-241
-
İstanbul Üniversitesi Adresli:
Hayır
Özet
Objective: Off-label drug use (OLDU) of neurologic diseases is approved by a regulatory authority, the Turkish Medicines and Medical Devices Agency (TMMDA) in Turkey. It was aimed to investigate the most common neurologic drugs relevant to off-label prescribing and the most prescribed diagnosis, demographic and medical characteristics of patients with OLDU applications in Turkey.